1
|
Effectiveness and sustainment of a tailored over-the-counter medication safety intervention in community pharmacies: A randomized controlled trial. Res Social Adm Pharm 2022; 18:3953-3963. [PMID: 35753964 PMCID: PMC9907172 DOI: 10.1016/j.sapharm.2022.06.008] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2022] [Accepted: 06/19/2022] [Indexed: 11/24/2022]
Abstract
INTRODUCTION The Senior Section is a continuation of a previous intervention that aims to address a gap in medication safety, specifically related to older adult selection and use of over-the-counter medications. The purpose of this paper is to describe the protocol of this study. METHODS This study will occur in three phases: an adaptation phase, an effectiveness phase using a randomized controlled trial, and a sustainment phase. This study will take place in conjunction with administrative leadership and pharmacy sites of a regional Midwest integrated health system. Eye tracking technology will inform the adaptation of the intervention and demonstrate effectiveness in the randomized controlled trial. Following the randomized controlled trial, the health system will implement the intervention without research team support. Fidelity and long-term effectiveness outcomes will be collected to demonstrate sustainment. DISCUSSION The potential implications of this study are a complete and sustained redesign of the pharmacy setting to include educational and directional materials on medication safety, leading to a decrease in over-the-counter medication misuse in older adults. This project could provide a road map for pharmacy organizations to tailor and adopt the Senior Section, to ultimately reduce inappropriate over-the-counter medication use in older adults.
Collapse
|
2
|
Nazar H, Nazar Z. Adopting a systems thinking approach to investigate the implementation and provision of a pharmacist-led post-discharge domiciliary medicines review service. Res Social Adm Pharm 2021; 17:808-815. [DOI: 10.1016/j.sapharm.2020.07.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/29/2020] [Revised: 07/16/2020] [Accepted: 07/16/2020] [Indexed: 11/29/2022]
|
3
|
Franco-Trigo L, Fernandez-Llimos F, Martínez-Martínez F, Benrimoj SI, Sabater-Hernández D. Stakeholder analysis in health innovation planning processes: A systematic scoping review. Health Policy 2020; 124:1083-1099. [PMID: 32829927 DOI: 10.1016/j.healthpol.2020.06.012] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2018] [Revised: 06/12/2020] [Accepted: 06/17/2020] [Indexed: 10/24/2022]
Abstract
Integrating health innovations into the health system is a complex endeavour that requires a well-designed planning process engaging key stakeholders. Stakeholder analyses lay the foundations to inform appropriate planning processes and undertake strategic actions. A systematic scoping review was performed to explore how stakeholder analyses are applied in health innovation planning processes and a guideline to report stakeholder analyses was developed. The literature search was conducted in PubMed, Scopus and DOAJ; grey literature was sought using Google. Articles reporting stakeholder analyses during the planning process of health policies, systems, products and technologies, and services and delivery methods were included. Fifty-one records were incorporated in the qualitative synthesis. Stakeholder analyses were conducted worldwide, used in all types of health innovations, applied in all phases of the planning process and conducted both prospectively and retrospectively. The steps followed to perform stakeholder analysis, the methods used, the stakeholder attributes analysed and how authors reported the analyses were heterogeneous. Forty-one studies reported the identification of stakeholders, 50 differentiated/categorised them and 25 analysed stakeholder relationships. Only some authors proposed future actions based on the results obtained in their stakeholder analysis. A list of Reporting Items for Stakeholder Analysis (i.e., the RISA tool) is proposed to contribute to the reporting guidelines to enhancing the quality and transparency of health research.
Collapse
Affiliation(s)
- L Franco-Trigo
- Graduate School of Health, University of Technology Sydney. Level 4, Building 7, 67 Thomas St. Ultimo. NSW 2007 PO Box 123, Australia; MJFD Academic Centre of Pharmaceutical Care, University of Granada. Faculty of Pharmacy, Campus Universitario Cartuja S/N, 18071, Granada, Spain; Pharmaceutical Care Research Group, University of Granada. Faculty of Pharmacy, Campus Universitario Cartuja S/N, 18071, Granada, Spain.
| | - F Fernandez-Llimos
- Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Portugal.
| | - F Martínez-Martínez
- MJFD Academic Centre of Pharmaceutical Care, University of Granada. Faculty of Pharmacy, Campus Universitario Cartuja S/N, 18071, Granada, Spain; Pharmaceutical Care Research Group, University of Granada. Faculty of Pharmacy, Campus Universitario Cartuja S/N, 18071, Granada, Spain.
| | - S I Benrimoj
- Graduate School of Health, University of Technology Sydney. Level 4, Building 7, 67 Thomas St. Ultimo. NSW 2007 PO Box 123, Australia.
| | - D Sabater-Hernández
- Graduate School of Health, University of Technology Sydney. Level 4, Building 7, 67 Thomas St. Ultimo. NSW 2007 PO Box 123, Australia; MJFD Academic Centre of Pharmaceutical Care, University of Granada. Faculty of Pharmacy, Campus Universitario Cartuja S/N, 18071, Granada, Spain; Pharmaceutical Care Research Group, University of Granada. Faculty of Pharmacy, Campus Universitario Cartuja S/N, 18071, Granada, Spain.
| |
Collapse
|
4
|
Handyside L, Warren R, Devine S, Drovandi A. Utilisation of the PRECEDE-PROCEED model in community pharmacy for health needs assessment: A narrative review. Res Social Adm Pharm 2020; 17:292-299. [PMID: 32253124 DOI: 10.1016/j.sapharm.2020.03.021] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2020] [Revised: 03/24/2020] [Accepted: 03/27/2020] [Indexed: 11/17/2022]
Abstract
BACKGROUND Health needs assessment tools such as the PRECEDE-PROCEED model (PPM) identify the key health concerns of communities, and may increase the capacity for community pharmacies to address these needs. OBJECTIVES A narrative review was conducted to investigate to what extent the PPM has been used to guide pharmacy service development and evaluation. METHODS A systematic search of six databases was conducted for peer-reviewed papers published from January 2000 to August 2019 that described the application of the PPM within the community pharmacy context. Search terms included variations of the following: 'pharmacists', 'precede proceed', 'pharmaceutical services', and 'community pharmacies'. Data extracted and analysed included study design, objectives, population, utilisation of the PPM, and outcomes. RESULTS Fourteen eligible papers were identified, most of which were cohort or cross-sectional studies and utilised at least one element of the PPM to design or evaluate interventions that targeted either patient behaviours or pharmacist behaviours, or evaluated population health needs or programs. The range of behaviours assessed was limited to patient medication adherence, and billing behaviours, readiness for expanded scope of practice, and communication for pharmacists. None of the studies prioritised community health needs, actively engaged all relevant stakeholders, or utilised every element of the PPM. CONCLUSIONS The PPM has been underutilised in community pharmacy research and represents an effective method for the assessment of health priorities for communities and the development and evaluation of health services targeted at addressing these priorities. Further research needs to demonstrate how key health needs assessment principles such as stakeholder engagement and a population-centred approach can influence effective health service delivery.
Collapse
Affiliation(s)
- Louisa Handyside
- College of Medicine and Dentistry, James Cook University, Townsville, Australia.
| | - Robin Warren
- Western Queensland Primary Health Network, Mount Isa, Australia.
| | - Sue Devine
- College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Australia.
| | - Aaron Drovandi
- College of Medicine and Dentistry, James Cook University, Townsville, Australia.
| |
Collapse
|
5
|
Development of a community pharmacy-based intervention to enhance adherence to adjuvant endocrine therapy among breast cancer survivors guided by the Intervention Mapping approach. Res Social Adm Pharm 2020; 16:1724-1736. [PMID: 32205070 DOI: 10.1016/j.sapharm.2020.02.004] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2019] [Revised: 01/31/2020] [Accepted: 02/09/2020] [Indexed: 02/07/2023]
Abstract
BACKGROUND Adjuvant endocrine therapy (AET) is prescribed for 5 or 10 years to women with non-metastatic breast cancer to reduce recurrence and mortality risks. However, AET adherence is suboptimal for many women. The few interventions specifically designed to enhance AET adherence and evaluated to date have provided inconclusive results. None of these interventions was offered in the community pharmacy setting. OBJECTIVE To describe the development of the PAcHA program, a community pharmacy-based intervention aiming to enhance AET adherence. METHODS The development of the intervention was guided by the six-step Intervention Mapping approach: needs assessment (Step 1); development of objectives matrices (Step 2); selection of theory-based intervention methods and practical applications (Step 3); development of the intervention program (Step 4); development of the adoption and implementation plan (Step 5); and evaluation plan (Step 6). Researchers, pharmacists and women prescribed AET were consulted at key steps. RESULTS The logic model was developed based on women's needs identified through a literature review and a qualitative study (Step 1). Optimal use of treatment for each woman with a new AET prescription was considered the behavioral outcome of the intervention. A woman is expected to: acquire knowledge about AET; make an informed decision about AET initiation and persistence; respect administration modalities and cope with side effects (Step 2). Motivational interviewing principles serve to guide the pharmacist intervention (Step 3). The intervention is brief and tailored to AET initiation and follow-up visits. Standardized intervention tools are available as support for pharmacists in their counseling (Step 4). An implementation plan was established, and web-based training was designed to train the pharmacists (Step 5). A cluster-randomized controlled trial was designed to evaluate the intervention (Step 6). CONCLUSION The systematic approach used for developing the intervention may increase its potential for being efficiently implemented and effective.
Collapse
|
6
|
Franco-Trigo L, Marqués-Sánchez P, Tudball J, Benrimoj SI, Martínez-Martínez F, Sabater-Hernández D. Collaborative health service planning: A stakeholder analysis with social network analysis to develop a community pharmacy service. Res Social Adm Pharm 2019; 16:216-229. [PMID: 31133537 DOI: 10.1016/j.sapharm.2019.05.008] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2018] [Revised: 04/27/2019] [Accepted: 05/17/2019] [Indexed: 11/28/2022]
Abstract
BACKGROUND Stakeholder participation optimizes health planning, fostering the acceptability and integration of new health services. Collaborative approaches may help overcome existing challenges in the development, implementation and evaluation of community pharmacy services (CPSs). Stakeholder analyses lay the foundation for building collaboration in the integrated delivery of health care. OBJECTIVES This stakeholder analysis was performed to organize a collaborative initiative to develop a CPS aimed at preventing cardiovascular diseases in Andalucía (Spain). It aimed to identify stakeholders, differentiate/categorize them, and analyze stakeholder relationships. METHOD Stakeholders were identified using the snowballing technique. To differentiate/categorize stakeholders and analyze the relationships (i.e., collaboration) an online web-based questionnaire was sent to 186 stakeholders. Stakeholders were asked for: (1) their influence, interest and attitude toward the initiative; (2) stakes/interests; (3) capacity to contribute to the initiative; (4) desire for involvement; (5) concerns; (6) whom they considered a key stakeholder; and (7) the level of collaboration they had with other stakeholders. Data analysis combined descriptive qualitative content analysis, descriptive quantitative analysis and social network analysis. RESULTS Of the 186 stakeholders approached, 96 (51.6%) participated. The identification process yielded 217 stakeholders (individuals, organizations or collectives), classified into 10 groups. Fifty-seven stakeholders were considered critical to the intended initiative. Most participant stakeholders supported the initiative and were willing to collaborate in the development of the CPS. Public health and science were the main driving interests. A collaboration network existed between the 96 stakeholders. CONCLUSION This study revealed the magnitude of the social system surrounding the development of a CPS aimed at preventing cardiovascular disease. A large array of stakeholders was identified and analyzed, and a group of critical stakeholders selected. Stakeholder characteristics such as attitude toward the initiative, potential contribution, desire for involvement, and the existing collaboration network, provided complementary information that was helpful for planning the process and stakeholder engagement.
Collapse
Affiliation(s)
- L Franco-Trigo
- Graduate School of Health, University of Technology Sydney. Level 4, Building 7, 67 Thomas St, Ultimo, NSW, 2007, (PO Box 123), Australia; MJFD Academic Centre of Pharmaceutical Care, University of Granada. Faculty of Pharmacy, Campus Universitario Cartuja S/N, 18071, Granada, Spain; Pharmaceutical Care Research Group, University of Granada. Faculty of Pharmacy, Campus Universitario Cartuja S/N, 18071, Granada, Spain.
| | - P Marqués-Sánchez
- SALBIS Research Group. Faculty of Health Sciences, University of Leon, Campus of Ponferrada s/n, 24401, Ponferrada, León, Spain.
| | - J Tudball
- Graduate School of Health, University of Technology Sydney. Level 4, Building 7, 67 Thomas St, Ultimo, NSW, 2007, (PO Box 123), Australia.
| | - S I Benrimoj
- Graduate School of Health, University of Technology Sydney. Level 4, Building 7, 67 Thomas St, Ultimo, NSW, 2007, (PO Box 123), Australia.
| | - F Martínez-Martínez
- MJFD Academic Centre of Pharmaceutical Care, University of Granada. Faculty of Pharmacy, Campus Universitario Cartuja S/N, 18071, Granada, Spain; Pharmaceutical Care Research Group, University of Granada. Faculty of Pharmacy, Campus Universitario Cartuja S/N, 18071, Granada, Spain.
| | - D Sabater-Hernández
- Graduate School of Health, University of Technology Sydney. Level 4, Building 7, 67 Thomas St, Ultimo, NSW, 2007, (PO Box 123), Australia; MJFD Academic Centre of Pharmaceutical Care, University of Granada. Faculty of Pharmacy, Campus Universitario Cartuja S/N, 18071, Granada, Spain; Pharmaceutical Care Research Group, University of Granada. Faculty of Pharmacy, Campus Universitario Cartuja S/N, 18071, Granada, Spain.
| |
Collapse
|
7
|
Applying participatory design to a pharmacy system intervention. Res Social Adm Pharm 2018; 15:1358-1367. [PMID: 30509852 DOI: 10.1016/j.sapharm.2018.11.012] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2018] [Revised: 11/24/2018] [Accepted: 11/25/2018] [Indexed: 11/22/2022]
Abstract
BACKGROUND Stakeholder engagement is an important component of the research process for improving the use and uptake of patient-centered health care innovations. Participatory design (PD), a method that utilizes the involvement of patients and other stakeholders, is well-suited for the design of multifaceted interventions in complex work systems, such as community pharmacies, that have diverse and dynamic end-users. OBJECTIVE The objective is to describe a blueprint for how to use PD when designing a community pharmacy intervention. This paper outlines the steps of PD and highlights the advantages and disadvantages of this method. METHODS PD is explained step-wise to underscore the considerations required of researchers unfamiliar with PD. This includes the development of a tailored PD approach, PD session preparatory work, data collection, and intervention development and evaluation. The stakeholders recruited for the community pharmacy intervention were pharmacy staff and older adult patients who received prescriptions at the pharmacy corporation in which the intervention was being implemented. The PD process was a series of six adaptive sessions: (1) problem identification, (2) solution generation, (3) convergence, (4) prototyping, (5) initial evaluation, and (6) formative evaluation. RESULTS A description of the PD process to design a community pharmacy intervention is provided. The process led to the development of a patient-centered prototype. The advantages of using PD included the opportunity to clarify problems faced by stakeholders, generation of novel solutions to incorporate into the intervention, and the ability to vet and fine-tune stakeholder design ideas in an iterative fashion. The insight gained was unprecedented and invaluable to the researchers. The biggest challenge of employing PD was the time-sensitive and time-intensive nature of developing each session, collecting data, and reflecting on the results in order to design subsequent sessions. CONCLUSIONS The PD process led to the development of a patient-centered prototype. PD enabled stakeholders to generate creative solutions and provide unique insight on addressing issues faced in healthcare redesign research and specifically in community pharmacies.
Collapse
|
8
|
Desselle SP, Hoh R, Holmes ER, Gill A, Zamora L. Pharmacy technician self-efficacies: Insight to aid future education, staff development, and workforce planning. Res Social Adm Pharm 2018; 14:581-588. [DOI: 10.1016/j.sapharm.2017.07.005] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2017] [Revised: 07/03/2017] [Accepted: 07/12/2017] [Indexed: 11/26/2022]
|
9
|
[Reflection on «Critical view and argumentation on chronic care programs in Primary and Community Care»]. Aten Primaria 2018; 51:118-120. [PMID: 29789166 PMCID: PMC6836983 DOI: 10.1016/j.aprim.2017.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2017] [Accepted: 12/22/2017] [Indexed: 11/20/2022] Open
|
10
|
Santina T, Lauzier S, Gagnon H, Villeneuve D, Moisan J, Grégoire JP, Guillaumie L. The Development of a Community Pharmacy-Based Intervention to Optimize Patients' Use of and Experience with Antidepressants: A Step-by-Step Demonstration of the Intervention Mapping Process. PHARMACY 2018; 6:pharmacy6020039. [PMID: 30720782 PMCID: PMC6025435 DOI: 10.3390/pharmacy6020039] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2018] [Revised: 04/18/2018] [Accepted: 04/23/2018] [Indexed: 11/16/2022] Open
Abstract
Objective: To describe the development of a community pharmacy-based intervention aimed at optimizing experience and use of antidepressants (ADs) for patients with mood and anxiety disorders. Methods: Intervention Mapping (IM) was used for conducting needs assessment, formulating intervention objectives, selecting change methods and practical applications, designing the intervention, and planning intervention implementation. IM is based on a qualitative participatory approach and each step of the intervention development process was conducted through consultations with a pharmacists' committee. Results: A needs assessment was informed by qualitative and quantitative studies conducted with leaders, pharmacists, and patients. Intervention objectives and change methods were selected to target factors influencing patients' experience with and use of ADs. The intervention includes four brief consultations between the pharmacist and the patient: (1) provision of information (first AD claim); (2) management of side effects (15 days after first claim); (3) monitoring treatment efficacy (30-day renewal); (4) assessment of treatment persistence (2-month renewal, repeated every 6 months). A detailed implementation plan was also developed. Conclusion: IM provided a systematic and rigorous approach to the development of an intervention directly tied to empirical data on patients' and pharmacists' experiences and recommendations. The thorough description of this intervention may facilitate the development of new pharmacy-based interventions or the adaptation of this intervention to other illnesses and settings.
Collapse
Affiliation(s)
- Tania Santina
- Faculty of Nursing, Université Laval, Pavillon Ferdinand-Vandry, 1050, Avenue de la Médecine, Quebec City, QC G1V 0A6, Canada.
| | - Sophie Lauzier
- Faculty of Pharmacy and Centre de Recherche du CHU de Québec-Université Laval, Hôpital Saint-Sacrement, 1050 Chemin Ste-Foy, Quebec City, QC G1S 4L8, Canada.
| | | | | | - Jocelyne Moisan
- Faculty of Pharmacy and Centre de Recherche du CHU de Québec-Université Laval, Hôpital Saint-Sacrement, 1050 Chemin Ste-Foy, Quebec City, QC G1S 4L8, Canada.
| | - Jean-Pierre Grégoire
- Faculty of Pharmacy and Centre de Recherche du CHU de Québec-Université Laval, Hôpital Saint-Sacrement, 1050 Chemin Ste-Foy, Quebec City, QC G1S 4L8, Canada.
| | - Laurence Guillaumie
- Faculty of Nursing, Université Laval, Pavillon Ferdinand-Vandry, 1050, Avenue de la Médecine, Quebec City, QC G1V 0A6, Canada.
| |
Collapse
|
11
|
Sabater-Hernández D, Tudball J, Ferguson C, Franco-Trigo L, Hossain LN, Benrimoj SI. A stakeholder co-design approach for developing a community pharmacy service to enhance screening and management of atrial fibrillation. BMC Health Serv Res 2018; 18:145. [PMID: 29486758 PMCID: PMC6389098 DOI: 10.1186/s12913-018-2947-7] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2017] [Accepted: 02/19/2018] [Indexed: 12/29/2022] Open
Abstract
Background Community pharmacies provide a suitable setting to promote self-screening programs aimed at enhancing the early detection of atrial fibrillation (AF). Developing and implementing novel community pharmacy services (CPSs) is a complex and acknowledged challenge, which requires comprehensive planning and the participation of relevant stakeholders. Co-design processes are participatory research approaches that can enhance the development, evaluation and implementation of health services. The aim of this study was to co-design a pharmacist-led CPS aimed at enhancing self-monitoring/screening of AF. Methods A 3-step co-design process was conducted using qualitative methods: (1) interviews and focus group with potential service users (n = 8) to identify key needs and concerns; (2) focus group with a mixed group of stakeholders (n = 8) to generate a preliminary model of the service; and (3) focus group with community pharmacy owners and managers (n = 4) to explore the feasibility and appropriateness of the model. Data were analysed qualitatively to identify themes and intersections between themes. The JeMa2 model to conceptualize pharmacy-based health programs was used to build a theoretical model of the service. Results Stakeholders delineated: a clear target population (i.e., individuals ≥65 years old, with hypertension, with or without previous AF or stroke); the components of the service (i.e., patient education; self-monitoring at home; results evaluation, referral and follow-up); and a set of circumstances that may influence the implementation of the service (e.g., quality of the service, competency of the pharmacist, inter-professional relationships, etc.). A number of strategies were recommended to enable implementation (e.g.,. endorsement by leading cardiovascular organizations, appropriate communication methods and channels between the pharmacy and the general medical practice settings, etc.). Conclusion A novel and preliminary model of a CPS aimed at enhancing the management of AF was generated from this participatory process. This model can be used to inform decision making processes aimed at adopting and piloting of the service. It is expected the co-designed service has been adapted to suit existing needs of patients and current care practices, which, in turn, may increase the feasibility and acceptance of the service when it is implemented into a real setting. Electronic supplementary material The online version of this article (10.1186/s12913-018-2947-7) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Daniel Sabater-Hernández
- Graduate School of Health, University of Technology, Level 4, Building 7, 67 Thomas St, PO Box 123, Ultimo, Sydney, Australia. .,Academic Centre in Pharmaceutical Care, University of Granada, Granada, Spain.
| | - Jacqueline Tudball
- Graduate School of Health, University of Technology, Level 4, Building 7, 67 Thomas St, PO Box 123, Ultimo, Sydney, Australia
| | - Caleb Ferguson
- Graduate School of Health, University of Technology, Level 4, Building 7, 67 Thomas St, PO Box 123, Ultimo, Sydney, Australia
| | - Lucía Franco-Trigo
- Graduate School of Health, University of Technology, Level 4, Building 7, 67 Thomas St, PO Box 123, Ultimo, Sydney, Australia.,Academic Centre in Pharmaceutical Care, University of Granada, Granada, Spain
| | - Lutfun N Hossain
- Graduate School of Health, University of Technology, Level 4, Building 7, 67 Thomas St, PO Box 123, Ultimo, Sydney, Australia
| | - Shalom I Benrimoj
- Graduate School of Health, University of Technology, Level 4, Building 7, 67 Thomas St, PO Box 123, Ultimo, Sydney, Australia
| |
Collapse
|
12
|
A stakeholder visioning exercise to enhance chronic care and the integration of community pharmacy services. Res Social Adm Pharm 2018; 15:31-44. [PMID: 29496521 DOI: 10.1016/j.sapharm.2018.02.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2017] [Revised: 12/22/2017] [Accepted: 02/15/2018] [Indexed: 11/24/2022]
Abstract
BACKGROUND Collaboration between relevant stakeholders in health service planning enables service contextualization and facilitates its success and integration into practice. Although community pharmacy services (CPSs) aim to improve patients' health and quality of life, their integration in primary care is far from ideal. Key stakeholders for the development of a CPS intended at preventing cardiovascular disease were identified in a previous stakeholder analysis. Engaging these stakeholders to create a shared vision is the subsequent step to focus planning directions and lay sound foundations for future work. OBJECTIVES This study aims to develop a stakeholder-shared vision of a cardiovascular care model which integrates community pharmacists and to identify initiatives to achieve this vision. METHODS A participatory visioning exercise involving 13 stakeholders across the healthcare system was performed. A facilitated workshop, structured in three parts (i.e., introduction; developing the vision; defining the initiatives towards the vision), was designed. The Chronic Care Model inspired the questions that guided the development of the vision. Workshop transcripts, researchers' notes and materials produced by participants were analyzed using qualitative content analysis. RESULTS Stakeholders broadened the objective of the vision to focus on the management of chronic diseases. Their vision yielded 7 principles for advanced chronic care: patient-centered care; multidisciplinary team approach; shared goals; long-term care relationships; evidence-based practice; ease of access to healthcare settings and services by patients; and good communication and coordination. Stakeholders also delineated six environmental factors that can influence their implementation. Twenty-four initiatives to achieve the developed vision were defined. CONCLUSIONS The principles and factors identified as part of the stakeholder shared-vision were combined in a preliminary model for chronic care. This model and initiatives can guide policy makers as well as healthcare planners and researchers to develop and integrate chronic disease services, namely CPSs, in real-world settings.
Collapse
|
13
|
Hossain LN, Fernandez-Llimos F, Luckett T, Moullin JC, Durks D, Franco-Trigo L, Benrimoj SI, Sabater-Hernández D. Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners. BMJ Open 2017; 7:e015471. [PMID: 28877940 PMCID: PMC5588935 DOI: 10.1136/bmjopen-2016-015471] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
OBJECTIVES The integration of community pharmacy services (CPSs) into primary care practice can be enhanced by assessing (and further addressing) the elements that enable (ie, facilitators) or hinder (ie, barriers) the implementation of such CPSs. These elements have been widely researched from the perspective of pharmacists but not from the perspectives of other stakeholders who can interact with and influence the implementation of CPSs. The aim of this study was to synthesise the literature on patients', general practitioners' (GPs) and nurses' perspectives of CPSs to identify barriers and facilitators to their implementation in Australia. METHODS A meta-synthesis of qualitative studies was performed. A systematic search in PubMed, Scopus and Informit was conducted to identify studies that explored patients', GPs' or nurses' views about CPSs in Australia. Thematic synthesis was performed to identify elements influencing CPS implementation, which were further classified using an ecological approach. RESULTS Twenty-nine articles were included in the review, addressing 63 elements influencing CPS implementation. Elements were identified as a barrier, facilitator or both and were related to four ecological levels: individual patient (n=14), interpersonal (n=24), organisational (n=16) and community and healthcare system (n=9). It was found that patients, nurses and GPs identified elements reported in previous pharmacist-informed studies, such as pharmacist's training/education or financial remuneration, but also new elements, such as patients' capability to follow service's procedures, the relationships between GP and pharmacy professional bodies or the availability of multidisciplinary training/education. CONCLUSIONS Patients, GPs and nurses can describe a large number of elements influencing CPS implementation. These elements can be combined with previous findings in pharmacists-informed studies to produce a comprehensive framework to assess barriers and facilitators to CPS implementation. This framework can be used by pharmacy service planners and policy makers to improve the analysis of the contexts in which CPSs are implemented.
Collapse
Affiliation(s)
- Lutfun N Hossain
- Graduate School of Health, University of Technology, Sydney, New South Wales, Australia
| | - Fernando Fernandez-Llimos
- Department of Social Pharmacy, Faculty of Pharmacy, Research Institute for Medicines, University of Lisbon, Lisboa, Portugal
| | | | - Joanna C Moullin
- Department of Psychiatry, University of California, San Diego, California, USA
| | - Desire Durks
- Graduate School of Health, University of Technology, Sydney, New South Wales, Australia
| | - Lucia Franco-Trigo
- Graduate School of Health, University of Technology, Sydney, New South Wales, Australia
| | - Shalom I Benrimoj
- Graduate School of Health, University of Technology, Sydney, New South Wales, Australia
| | - Daniel Sabater-Hernández
- Graduate School of Health, University of Technology, Sydney, New South Wales, Australia
- Academic Centre in Pharmaceutical Care, University of Granada, Granada, Spain
| |
Collapse
|
14
|
Franco-Trigo L, Hossain L, Durks D, Fam D, Inglis S, Benrimoj S, Sabater-Hernández D. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease. Res Social Adm Pharm 2017; 13:539-552. [DOI: 10.1016/j.sapharm.2016.06.009] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2016] [Revised: 06/16/2016] [Accepted: 06/19/2016] [Indexed: 10/21/2022]
|
15
|
Sabater-Hernández D, Sabater-Galindo M, Fernandez-Llimos F, Rotta I, Hossain LN, Durks D, Franco-Trigo L, Lopes LA, Correr CJ, Benrimoj SI. A Systematic Review of Evidence-Based Community Pharmacy Services Aimed at the Prevention of Cardiovascular Disease. J Manag Care Spec Pharm 2017; 22:699-713. [PMID: 27231797 PMCID: PMC10398089 DOI: 10.18553/jmcp.2016.22.6.699] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
BACKGROUND Cardiovascular disease (CVD) is the leading cause of death worldwide and has a substantial impact on people's health and quality of life. CVD also causes an increased use of health care resources and services, representing a significant proportion of health care expenditure. Integrating evidence-based community pharmacy services is seen as an asset to reduce the burden of CVD on individuals and the health care system. OBJECTIVES To (a) identify community pharmacy evidence-based services designed to help prevent CVD and (b) provide fundamental information that is needed to assess their potential adaptation to other community pharmacy settings. METHODS This review used the DEPICT database, which includes 488 randomized controlled trials (RCT) that address the evaluation of pharmacy services. Articles reviewing these RCTs were identified for the DEPICT database through a systematic search of the following databases: MEDLINE, Scopus, SciELO (Scientific Electronic Library Online), and DOAJ (Directory of Open Access Journals). The DEPICT database was reviewed to identify evidence-based services delivered in the community pharmacy setting with the purpose of preventing CVD. An evidence-based service was defined as a service that has been shown to have a positive effect (compared with usual care) in a high-quality RCT. From each evidence-based service, fundamental information was retrieved to facilitate adaptation to other community pharmacy settings. RESULTS From the DEPICT database, 14 evidence-based community pharmacy services that addressed the prevention of CVD were identified. All services, except 1, targeted populations with a mean age above 60 years. Pharmacy services encompassed a wide range of practical applications or techniques that can be classified into 3 groups: activities directed at patients, activities directed at health care professionals, and assessments to gather patient-related information in order to support the previous activities. CONCLUSIONS This review provides pharmacy service planners and policymakers with a comprehensive list of evidence-based services that have the potential to be adapted to different settings from which they were originally implemented and evaluated in order to reduce the burden of CVD. DISCLOSURES Funding for this review was provided by the University of Technology Sydney Chancellor's Postdoctoral Fellowship awarded to Sabater-Hernández. No other potential conflict of interest was declared. Study concept and design were contributed by Sabater-Hernández, Fernandez-Llimos, Rotta, and Correr. Sabater-Galindo and Sabater-Hernández took the lead in data collection, along with Franco-Trigo and Rotta. Data interpretation was performed by Sabater-Hernández, Durks, and Lopes. The manuscript was written primarily by Sabater-Hernández, along with Hossain, and revised by Fernandez-Llimos, Rotta, and Benrimoj, with assistance from Durks, Sabater-Galindo, Franco-Trigo, and Correr.
Collapse
Affiliation(s)
- Daniel Sabater-Hernández
- 1 Graduate School of Health (UTS: Pharmacy), University of Technology Sydney, Sydney, Australia, and Academic Centre in Pharmaceutical Care, University of Granada, Granada, Spain
| | | | - Fernando Fernandez-Llimos
- 3 Research Institute for Medicines (iMed.ULisboa), Department of Social Pharmacy, Faculty of Pharmacy, University of Lisboa, Lisbon, Portugal
| | - Inajara Rotta
- 4 PostGraduate Program of Pharmaceutical Sciences, Federal University of Parana
| | - Lutfun N Hossain
- 7 Graduate School of Health (UTS: Pharmacy), University of Technology Sydney, Sydney, Australia
| | - Desire Durks
- 8 Graduate School of Health (UTS: Pharmacy), University of Technology Sydney, Sydney, Australia
| | - Lucia Franco-Trigo
- 9 School of Health (UTS: Pharmacy), University of Technology Sydney, Sydney, Australia
| | - Livia A Lopes
- 5 Post-Graduate Program of Pharmaceutical Sciences, Federal University of Parana
| | - Cassyano J Correr
- 6 Department of Pharmacy, Federal University of Parana, Curitiba, Brazil
| | - Shalom I Benrimoj
- 10 School of Health University of Technology Sydney, Sydney, Australia
| |
Collapse
|
16
|
Kerstenetzky L, Birschbach MJ, Beach KF, Hager DR, Kennelty KA. Improving medication information transfer between hospitals, skilled-nursing facilities, and long-term-care pharmacies for hospital discharge transitions of care: A targeted needs assessment using the Intervention Mapping framework. Res Social Adm Pharm 2017; 14:138-145. [PMID: 28455194 DOI: 10.1016/j.sapharm.2016.12.013] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2016] [Revised: 12/01/2016] [Accepted: 12/16/2016] [Indexed: 10/19/2022]
Abstract
INTRODUCTION Patients transitioning from the hospital to a skilled nursing home (SNF) are susceptible to medication-related errors resulting from fragmented communication between facilities. Through continuous process improvement efforts at the hospital, a targeted needs assessment was performed to understand the extent of medication-related issues when patients transition from the hospital into a SNF, and the gaps between the hospital's discharge process, and the needs of the SNF and long-term care (LTC) pharmacy. We report on the development of a logic model that will be used to explore methods for minimizing patient care medication delays and errors while further improving handoff communication to SNF and LTC pharmacy staff. METHODS Applying the Intervention Mapping (IM) framework, a targeted needs assessment was performed using quantitative and qualitative methods. Using the hospital discharge medication list as reference, medication discrepancies in the SNF and LTC pharmacy lists were identified. SNF and LTC pharmacy staffs were also interviewed regarding the continuity of medication information post-discharge from the hospital. RESULTS At least one medication discrepancy was discovered in 77.6% (n = 45/58) of SNF and 76.0% (n = 19/25) of LTC pharmacy medication lists. A total of 191 medication discrepancies were identified across all SNF and LTC pharmacy records. Of the 69 SNF staff interviewed, 20.3% (n = 14) reported patient care delays due to omitted documents during the hospital-to-SNF transition. During interviews, communication between the SNF/LTC pharmacy and the discharging hospital was described by facility staff as unidirectional with little opportunity for feedback on patient care concerns. CONCLUSIONS The targeted needs assessment guided by the IM framework has lent to several planned process improvements initiatives to help reduce medication discrepancies during the hospital-to-SNF transition as well as improve communication between healthcare entities. Opening lines of communication along with aligning healthcare entity goals may help prevent medication-related errors.
Collapse
Affiliation(s)
- Luiza Kerstenetzky
- UW Health - Department of Pharmacy, 600 Highland Avenue, Madison, WI, 53792, United States.
| | - Matthew J Birschbach
- UW Health - Department of Pharmacy, 600 Highland Avenue, Madison, WI, 53792, United States; University of Wisconsin - Madison, School of Pharmacy, 777 Highland Avenue, Madison, WI, 53705, United States.
| | - Katherine F Beach
- UW Health - Department of Pharmacy, 600 Highland Avenue, Madison, WI, 53792, United States; University of Wisconsin - Madison, School of Pharmacy, 777 Highland Avenue, Madison, WI, 53705, United States.
| | - David R Hager
- UW Health - Department of Pharmacy, 600 Highland Avenue, Madison, WI, 53792, United States.
| | - Korey A Kennelty
- University of Wisconsin - Madison, School of Pharmacy, 777 Highland Avenue, Madison, WI, 53705, United States; Department of Pharmacy Practice and Science, University of Iowa, College of Pharmacy, 115 S Grand Ave, Iowa City, IA, 52242, United States.
| |
Collapse
|